Integrative Metabolomics Differentiate Coronary Artery Disease, Peripheral Artery Disease, and Venous Thromboembolism Risks.
Jiwoo LeeThomas C GillilandJacqueline S DronSatoshi KoyamaTetsushi NakaoKim LanneryMegan WongGina M PelosoWhitney E HornsbyPradeep NatarajanPublished in: Arteriosclerosis, thrombosis, and vascular biology (2024)
While common vascular conditions are associated with overlapping metabolomic profiles, MR prioritized the role of specific lipoprotein species for potential pharmacological targets to maximize benefits in both arterial and venous beds.
Keyphrases
- peripheral artery disease
- venous thromboembolism
- coronary artery disease
- human health
- direct oral anticoagulants
- mass spectrometry
- percutaneous coronary intervention
- risk assessment
- cardiovascular events
- coronary artery bypass grafting
- contrast enhanced
- magnetic resonance
- network analysis
- climate change
- low density lipoprotein
- type diabetes
- cardiovascular disease
- magnetic resonance imaging
- atrial fibrillation
- transcatheter aortic valve replacement